Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT05053230

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +31 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations
  • Kaiser Permanente-Division of Research Pleasanton, California, United States
  • Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
  • Kaiser Permanente-Franklin Denver, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 39 locations
View Trial Details
Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594

Conditions
Adnexal Diseases, Advanced Solid Malignancies, Astrocytoma, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Chicago, Illinois, United States
View all 32 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +40 more
Locations
  • Ellison Clinic at Saint John's Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 65 locations
View Trial Details

Related conditions